glp 1 agonist metformin GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes metformin and glp 1 for
Description
Previous research has linked GLP-1 drugs to a sudden, vision-threatening condition called nonarteritic anterior ischemic optic neuropathy (NAION) and to wet age-related macular degeneration
doi: 10.1016/S0140-6736(25)01375-3
GLP-1 users saw a 44% reduction in hospitalizations due to stroke, heart attack and heart failure compared to the control group
13 at the annual JPMorgan Healthcare Conference in San Francisco
The absolute incidence of pancreatitis in clinical trials has been consistently low across studies, typically affecting fewer than 1 in 200 patients over multi-year follow-up periods
